1) Heparin, (1989) (Eds.: Lane, D. A. and Lindahl, U.), CRC Press Inc., Boca Raton, FL, and references therein.
2) Esko, J. D. (1999) in Essentials of Glycobiology, (Eds.: Varki, A., Cummings, R., Esko, J., Freeze, H., Hart, G., and Marth, J.), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, NY, pp. 441-453, and references therein.
3) Gallagher, J. (2001) Heparan sulfate: growth control with a restricted sequence menu. J. Clinic. Invest. 108, 357.
4) Ostrovsky, O., Berman, B., Gallagher, J., Mulloy, B., Fernig, D. G., Delehedde, M., and Ron, D. (2001) Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes. J. Biol. Chem. 277, 2444.
5) Faham, S., Hileman, R. E., Fromm, J. R., Linhardt, R. J., Rees, D. C. (1996) Heparin structure and interactions with basic fibroblast growth factor. Science 271, 1116.
6) Choay, J., Lormeau, J. -C., Petitou, M., Sinay, P. and Fareed, J. (1981) Structural studies on a biologically active hexasaccharide obtained from heparin. Ann. New York Acad. Sci., 370, 644.
7) Thunberg, L., Backstrom, G. and Lindahl, U. (1982) Further characterization of the antithrombin-binding sequence in heparin. Carbohydr. Res., 100, 393.
8) Salzman, E. W., Rosenberg, R. D., Smith, M. H., Lindon, J. N. and Favreau, L. (1980) Effect of heparin and heparin fractions on platelet aggregation. J. Clin. Invest., 65, 64.
9) Suda, Y., Marques, D., Kermode, J. C., Kusumoto, S. and Sobel, M. (1993) Structural characterization of heparin's binding domain for human platelets. Thromb. Res., 69, 501.
10) Sobel, M., Ottenbrite, R. M. and Suda, Y. (1991) Fluorescent labeling of heparins and related polysaccharides: Old problems and new solutions, in:Polymeric Drugs and Drug Delivery systems (Eds.: Dunn, R. L. and Ottenbrite, R. M.), ACS Symposium Series 469, American Chemical Society, Washington D. C., pp. 60.
11) Suda, Y., Bird, K., Shiyama, T., Koshida, S., Marques, D., Fukase, K., Sobel, M. and Kusumoto, S. (1996) Synthesis and biological activity of a model disaccharide containing a key unit in heparin for binding to platelets, Tetrahedron Lett., 37, 1053.
12) Koshida, S., Suda, Y., Fukui, Y., Ormsby, J., Sobel, M., and Kusumoto, S. (1999) Synthesis and biological activity of oligomer-model compounds containing units of a key platelet-binding disaccharide of heparin. Tetrahedron Lett. 40 (21), 5725.
13) Koshida, S., Suda, Y., Arano A., Sobel, M., and Kusumoto, S. (2001) An efficient method for the assembly of sulfated oligosaccharides using reductive amination. Tetrahedron Lett. 42 (7), 1293.
14) Koshida, S., Suda, Y., Sobel, M., and Kusumoto, S. (2001) Synthesis of oligomeric assemblies of a platelet-binding key disaccharide in heparin and their biological activities. Tetrahedron Lett. 42 (7), 1289.
15) Sobel, M., McNeill, P. M., Carlson, P.L., Kermode, J. C., Adelman, B., Conroy, R. and Marques, D. (1991) Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo. J Clin Invest., 87, 1787.
16) Poletti, L. F., Bird, K. E., Marques, D., Harris, R. B., Suda, Y., and Sobel, M. (1997) Structural aspects of heparin responsible for interactions with von Willebrand factor. Arterioscler. Thromb. Vasc. Biol. 17 (5), 925.
17) Suda, Y., Arano, A., Fukui, Y., Koshida, S., Wakao, M., Nishimura, T., Kusumoto, S. and Sobel, M. (2006) Immobilization and clustering of structurally defined oligosaccharides for sugar chips: an improved method for surface plasmon resonance analysis of protein-carbohydrate interactions. Bioconjug Chem., 17, 1125.
18) Peterlinz, K. A., and Georgiadis, R. (1996) In situ kinetics of self-assembly by surface plasmon resonance spectroscopy. Langmuir 12 (20), 4731.
19) Liedberg, B., Nylander, C., and Lundströ I. (1983) Surface plasmon resonance for gas detection and biosensing. Sensors and Actuators 4, 299.
20) 隅田泰生 ”糖鎖チップ“ (2005) 糖鎖科学の新展開-機能解明・次世代型材料・医薬品開発に向けて（谷口直之、伊藤幸成 編）エヌティーエヌ、pp. 471.
21) Sobel, M., Soler, D. F., Kermode, J. C., and Harris, R. B. (1992) Localization and characterization of a heparin binding domain peptide of human von Willebrand factor. J. Biol. Chem. 267, 8857.
22) Cruz, M. A., Handin, R. I., Wise, R. J. (1993) The Interaction of the von Willebrand Factor A1 Domain with Platelet Glycoprotein Ib Ix ﾐ The role of glycosylation and disulfide bonding in a monomeric recombinant A1 domain protein. J. Biol. Chem. 1993, 268, 21238.
23) Rastegar-Lari, G., Villoutreix, B. O., Ribba, A.S., Legendre, P., Meyer, D., and Baruch, D. (2002) Two clusters of charged residues located in the electropositive face of the von Willebrand factor A1 domain are essential for heparin binding. Biochemistry 41, 6668.
24) Ashton, P. R., Boyd, S. E., Brown, C. L., Nepogodiev, S. A., Meijer, E. W., Peerlings, H. W. I., and Stoddart, J. E. (1997) Synthesis of glycodndrimers by modification of poly(propylene imine) dendrimers. Chemistry-A Eur. J. 3, 974.
25) Presta, M., Maier, J. A., Rusnati, M., and Ragnotti, G. (1989) Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form. J. Cell. Physiol. 140, 68.
26) Suda, Y., Kishimoto, Y., Nishimura, T., Yamashita, S., Hamamatsu, M., Saito, A., Sato, M., and Wakao, M (2006) Sugar-immobilized gold nano-particles (SGNP): Novel bioprobe for the on-site analysis of the oligosaccharide protein interactions, Polymer Preprints 47(2), 156.
27) URL http://www.sudxbiotec.jp/
28) Houseman, B. T., and Mrksich, M. (2002) Carbohydrate arrays for the evaluation of protein binding and enzymatic modification. Chem. Biol. 9, 443.
29) Fazio, F., Bryan, M. C., Blixt, O., Paulson, J. C., and Wong, C. -H. (2002) Synthesis of sugar arrays in microtiter plate. J. Am. Chem. Soc. 124 (48), 14397.
30) Park, S., Lee, M. -R., Pyo, S. -J., and Shin, I. (2002) Carbohydrate chips for studying high-throughput carbohydrate-protein interactions. J. Am. Chem. Soc. 126 (15), 4812.
31) Ratner, D. M., Adams, E. W., Su, J., OﾕKeefe, B. R., Mrksich, M., and Seeberger, P. H. (2004) Probing proteinﾐcarbohydrate interactions with microarrays of synthetic oligosaccharides. ChemBioChem. 5, 379.
32) de Paz, J. L., Noti, C., and Seeberger P. H. (2006) Microarrays of synthetic heparin oligosaccharides. J. Am. Chem. Soc., 128, 2766.
33) Feizi, T., and Chai, W. (2004) Oligosaccharide microarrays to decipher the glyco code. Nature Reviews, 5, 582.